InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

RegulatoryapprovedTavneosPositive

AI Analysis

Summary

InflaRx received an EMA recommendation for Tavneos in ANCA-Associated Vasculitis and is evaluating expansion of its strategy for the indication in Europe.

Outcome Details

EMA recommendation for Tavneos

Importance:7/10

Sentiment:

0.70

EMA approvalEuropean expansionTavneosANCA-Associated Vasculitisregulatory

Related Companies

$IFRX

Read the original article

Published by yahoo_finance on June 30, 2026 11:30 AM

Read Original